4//SEC Filing
Morrow Phuong Khanh 4
Accession 0001209191-22-053496
CIK 0001674416other
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 5:41 PM ET
Size
5.4 KB
Accession
0001209191-22-053496
Insider Transaction Report
Form 4
Morrow Phuong Khanh
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-10-07+9,380→ 9,380 totalExercise: $61.65Exp: 2032-10-07→ Common Shares (9,380 underlying)
Footnotes (1)
- [F1]This option was granted on October 7, 2022 with respect to 9,380 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 7, 2022.
Documents
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0001928989
Filing Metadata
- Form type
- 4
- Filed
- Oct 11, 8:00 PM ET
- Accepted
- Oct 12, 5:41 PM ET
- Size
- 5.4 KB